Research.Patient.info
Idiopathic Pulmonary Fibrosis research hub
2 indexed studies · 1 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
A Two-Cohort, Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared with Placebo in Patients with Idiopathic Pulmonary Fibrosis and in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
This study is testing a new medicine, Vixarelimab, for two serious lung conditions: Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease. It aims to see if the medicine can improve lung function and safety compared to a dummy treatment.
Germany · Hungary · Italy - recruitingPHASE2, PHASE3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
This study looks at a new treatment called belimumab for adults with a lung condition linked to scleroderma. Researchers want to see if it improves lung function and other symptoms, like skin thickening, compared to a dummy treatment.
United States · Argentina · Australia